Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Current Medical Research and Opinion|January 29, 2020
Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorderGang Wang, Kun Zhao, Caroline Reynaud-Mougin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 23, 2024
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysisEsteban J Gimeno, Mette Bøgelund, Sara Larsen, et al.
Frontiers in Psychiatry|March 31, 2022
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE StudyGregory W Mattingly, Hongye Ren, Michael Cronquist Christensen, et al.
European Stroke Journal|February 14, 2025
Type 2 diabetes in stroke patients: Impact on outcomes, recurrence, resource use, and costs in FranceIgor Sibon, Kamel Mohammedi, Nadia Quignot, et al.
Cardiovascular Diabetology|May 29, 2024
Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" studyKamel Mohammedi, Laurent Fauchier, Nadia Quignot, et al.
Neuropsychiatric Disease and Treatment|September 6, 2022
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China StudyGang Wang, Le Xiao, Hongye Ren, et al.
European Journal of Heart Failure|May 10, 2026
Prevalence and Predictors of High Inflammatory Risk in Heart Failure Subtypes: Findings From the Global POSEIDON StudyCarolyn S P Lam, Johanna Contreras, Raed Darwesh, et al.
Atherosclerosis|July 9, 2026
Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON studyAnn Marie Navar, Ling Bai, Jesper Falkesgaard Højen, et al.
Pageof 3